Literature DB >> 15647627

New horizons in the analysis of circulating cell-derived microparticles.

Lawrence L Horstman1, Wenche Jy, Joaquin J Jimenez, Carlos Bidot, Yeon S Ahn.   

Abstract

Analysis of circulating cell-derived microparticles (MP) is becoming more refined and clinically useful. This review, stemming from lectures given at Tokyo late 2003, does not repeat prior reviews but focuses on new horizons. A major theme is the rising recognition of platelets and their MP (PMP) as key mediators of inflammation/immunity. Among the major concepts developed are that (i) many so-called soluble markers of inflammation are in reality MP-bound; (ii) PMP and other MP appear to serve important signaling and immune functions including antigen presentation. In conclusion, MP analysis is poised to enter the mainstream of clinical testing, measuring specific antigens rather than gross levels. However, more research is needed to decisively establish their functions, and international standards are needed to allow comparing results from different laboratories.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15647627     DOI: 10.2302/kjm.53.210

Source DB:  PubMed          Journal:  Keio J Med        ISSN: 0022-9717


  36 in total

1.  Methodology for isolation, identification and characterization of microvesicles in peripheral blood.

Authors:  Muthuvel Jayachandran; Virginia M Miller; John A Heit; Whyte G Owen
Journal:  J Immunol Methods       Date:  2011-10-29       Impact factor: 2.303

Review 2.  Isolation and characterization of urinary extracellular vesicles: implications for biomarker discovery.

Authors:  Michael L Merchant; Ilse M Rood; Jeroen K J Deegens; Jon B Klein
Journal:  Nat Rev Nephrol       Date:  2017-10-30       Impact factor: 28.314

Review 3.  Microparticle analysis in disorders of hemostasis and thrombosis.

Authors:  Micah J Mooberry; Nigel S Key
Journal:  Cytometry A       Date:  2015-02-20       Impact factor: 4.355

Review 4.  Microparticles and cardiovascular diseases.

Authors:  Christos Voukalis; Eduard Shantsila; Gregory Y H Lip
Journal:  Ann Med       Date:  2019-06-17       Impact factor: 4.709

5.  Platelet microparticles infiltrating solid tumors transfer miRNAs that suppress tumor growth.

Authors:  James V Michael; Jeremy G T Wurtzel; Guang Fen Mao; A Koneti Rao; Mikhail A Kolpakov; Abdelkarim Sabri; Nicholas E Hoffman; Sudarsan Rajan; Dhanendra Tomar; Muniswamy Madesh; Marvin T Nieman; Johnny Yu; Leonard C Edelstein; Jesse W Rowley; Andrew S Weyrich; Lawrence E Goldfinger
Journal:  Blood       Date:  2017-05-12       Impact factor: 22.113

6.  Catabolic effects of endothelial cell-derived microparticles on disc cells: Implications in intervertebral disc neovascularization and degeneration.

Authors:  Pedro H I Pohl; Thomas P Lozito; Thais Cuperman; Takashi Yurube; Hong J Moon; Kevin Ngo; Rocky S Tuan; Claudette St Croix; Gwendolyn A Sowa; Luciano M R Rodrigues; James D Kang; Nam V Vo
Journal:  J Orthop Res       Date:  2016-06-14       Impact factor: 3.494

7.  Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasis.

Authors:  Eric T Alexander; Allyson R Minton; Candace S Hayes; Ashley Goss; Joanne Van Ryn; Susan K Gilmour
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

Review 8.  Do galectins play a role in venous thrombosis? a review.

Authors:  Jose A Diaz; Eduardo Ramacciotti; Thomas W Wakefield
Journal:  Thromb Res       Date:  2009-12-02       Impact factor: 3.944

9.  MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome.

Authors:  QiQi Zhou; Wiley W Souba; Carlo M Croce; G Nicholas Verne
Journal:  Gut       Date:  2009-12-01       Impact factor: 23.059

Review 10.  The role of microparticles in the pathogenesis of rheumatic diseases.

Authors:  Christian Beyer; David S Pisetsky
Journal:  Nat Rev Rheumatol       Date:  2009-12-01       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.